Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4223)

Showing 12 of 4223 View All
Showing 146 of 352 pages

Gavi Board approves malaria vaccine programme funding, COVAX 2022 strategic approach and measures to maintain, restore and strengthen routine immunisation

A new malaria vaccination programme has been approved, providing Gavi-eligible countries in sub-Saharan Africa a powerful new tool with which to fight malaria.

"The vaccine has done wonders”: Kenya’s experience with the world’s first malaria vaccine

The Gavi Board has approved the roll-out of RTS,S/AS01, the world’s first vaccine against malaria, a sickness which kills 260,000 children under five in sub-Saharan Africa every year. To get a sense of what this historic development might mean on…

When will life return to normal after the pandemic?

Surveying by the Office for National Statistics shows Brits are increasingly pessimistic about things returning to how they were before.

Gavi Board approves funding to support malaria vaccine roll-out in sub-Saharan Africa

A new malaria vaccination programme will support Gavi-eligible countries to implement a new tool in the fight against malaria in sub-Saharan Africa in 2022-2025, including vaccine introduction, procurement and delivery

A Ghanaian doctor’s perspective on COVID-19 vaccine inequity

Pre-COVID-19, Ghana’s health system was overburdened. The virus has made everything harder, and vaccine inequity has made it harder still.

New Zealand kicks off 2022 COVAX fundraising efforts with NZ$ 9 million funding pledge

One of the first COVAX funders and first dose donors, New Zealand has again stepped up and pledged NZ$ 9 million in funding to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). This funding will help COVAX better respond to country needs…

Growing viral: health, hope, and happiness in the time of COVID and HIV

Living with one lethal virus, the children of Snehagram in southern India bolster each other in surviving the coronavirus pandemic.

Mask wearing wasn’t disputed in previous crises – so why is it so hotly contested today?

How the pandemic is reported by the media can influence people's behaviour.

How next-generation COVID-19 vaccines could help to end the pandemic

A year ago, we had no COVID-19 vaccines, now we have many. Could the next generation of vaccines be better still?

The hunt for coronavirus variants: how the new one was found and what we know so far

There's a new COVID lineage called B.1.1.529. It has a genetic profile very different from other circulating variants.

There's Only One Way to Stop the Emergence of Variants Like Omicron

"This crisis is far from over, and without dramatic course correction, will go on for some time."

Omicron: why the WHO designated it a variant of concern

Not much data, but lessons have been learned from the slow response to delta.

Subscribe to our newsletter